BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27797254)

  • 1. Hepatitis C Virus Associations with Non Hodgkin's Lymphoma: Insights on Inflammation/Angiogenesis and CD Markers.
    El-Maadawy EA; Talaat RM; Sadek RF; El-Sherbini SM; Abdel-Bary N; Abdel-Aziz AA
    Asian Pac J Cancer Prev; 2016; 17(9):4415-4420. PubMed ID: 27797254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.
    el-Din HM; Attia MA; Hamza MR; Khaled HM; Thoraya MA; Eisa SA
    Egypt J Immunol; 2004; 11(1):55-64. PubMed ID: 15724387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
    El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
    Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
    Barrett S; Collins M; Kenny C; Ryan E; Keane CO; Crowe J
    J Med Virol; 2003 Oct; 71(2):212-8. PubMed ID: 12938195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
    Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
    Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-Hodgkin's lymphoma and hepatitis C virus infection].
    Ennibi K; Bechade D; Rabhi M; Coutant G; Toloune F; Desrame J; Archane MI; Algayres JP
    Rev Med Interne; 2003 Jul; 24(7):452-8. PubMed ID: 12829218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
    Engels EA; Chatterjee N; Cerhan JR; Davis S; Cozen W; Severson RK; Whitby D; Colt JS; Hartge P
    Int J Cancer; 2004 Aug; 111(1):76-80. PubMed ID: 15185346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
    Ferri C; Caracciolo F; Zignego AL; La Civita L; Monti M; Longombardo G; Lombardini F; Greco F; Capochiani E; Mazzoni A
    Br J Haematol; 1994 Oct; 88(2):392-4. PubMed ID: 7803287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study].
    Catassi C; Fabiani E; Coppa GV; Gabrielli A; Centurioni R; Leoni P; Barbato M; Viola F; Martelli M; De Renzo A; Rotoli B; Bertolani P; Federico M; Carroccio A; Iannitto E; Baldassarre M; Guarini A; Guariso G; Favaretto G; Caramaschi P; Ambrosetti A
    Recenti Prog Med; 1998 Feb; 89(2):63-7. PubMed ID: 9558907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus association with non-Hodgkin's lymphoma.
    Timurağlu A; Colak D; Oğünç D; Karadoğan I; Undar L
    Haematologia (Budap); 1999; 29(4):301-4. PubMed ID: 10438070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis by IL-32: possible role in asthma.
    Meyer N; Christoph J; Makrinioti H; Indermitte P; Rhyner C; Soyka M; Eiwegger T; Chalubinski M; Wanke K; Fujita H; Wawrzyniak P; Bürgler S; Zhang S; Akdis M; Menz G; Akdis C
    J Allergy Clin Immunol; 2012 Apr; 129(4):964-73.e7. PubMed ID: 22336080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma.
    Paydas S; Kilic B; Yavuz S; Disel U; Tanriverdi K; Sahin B; Burgut R
    Am J Hematol; 2003 Oct; 74(2):89-93. PubMed ID: 14508793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas.
    Chindamo MC; Spector N; Segadas JA; Pimenta G; Vanderborght B; Morais JC; Milito C; Moraes Coelho HS
    Oncol Rep; 2002; 9(3):657-9. PubMed ID: 11956646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
    Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.